Nasus Pharma Ltd. (NYSEAMERICAN:NSRX – Get Free Report)’s share price fell 4% on Thursday. The company traded as low as $3.50 and last traded at $3.63. 14,033 shares changed hands during mid-day trading, a decline of 37% from the average session volume of 22,397 shares. The stock had previously closed at $3.78.
Nasus Pharma Stock Performance
The firm’s 50 day moving average price is $3.65 and its 200-day moving average price is $3.19.
Nasus Pharma (NYSEAMERICAN:NSRX – Get Free Report) last announced its quarterly earnings results on Monday, August 17th. The company reported ($0.27) earnings per share for the quarter. As a group, research analysts predict that Nasus Pharma Ltd. will post -0.84 earnings per share for the current year.
About Nasus Pharma
Nasus Pharma Ltd. is a clinical-stage specialty pharmaceutical company developing intranasal powder-delivery products for acute care and emergency medical conditions. Its proprietary platform is designed to deliver drug formulations through the nose in a convenient, needle-free format, with the potential to support rapid administration when patients may be unable to swallow or when immediate treatment is needed.
The company’s development activities focus on applying its technology to treatments for conditions that require fast, simple dosing, including emergency and hospital-based applications.
Further Reading
- Five stocks we like better than Nasus Pharma
- 3 Beaten-Down Biotech Stocks With Triple-Digit Upside and Big Catalysts Ahead
- Schneider Just Paid Up for PTC—Is the SaaSpocalypse Overdone?
- Delta Air Lines Faces a Fuel Crisis—But There’s a Silver Lining
- Is Synopsys Back from the Dead? EDA Leader Inks Deals With Amazon and OpenAI
Receive News & Ratings for Nasus Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nasus Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
